Skip to main content
Industry News
Small study tests convalescent plasma for severe COVID-19

A study of 39 people with severe COVID-19 who received convalescent plasma found lower rates of mortality and and less need for oxygen supplementation after 14 days than in 156 similar patients who did not receive convalescent plasma. Researchers cautioned in the journal Nature Medicine that the study was not a randomized controlled trial and said more trials are needed.

Full Story: